UiPath (NYSE:PATH) Receives "Sell (D)" Rating from Weiss Ratings

Key Points

• UiPath's stock rating was reaffirmed as "sell (D)" by Weiss Ratings, indicating analysts' negative outlook.
• Despite the sell rating, UiPath's stock saw a 5.2% increase in value, reaching $15.59 in midday trading.
• The company reported earnings of $0.15 per share for the last quarter, beating expectations and showing a 14.6% increase in revenue compared to the previous year.

UiPath (NYSE:PATH - Get Free Report)'s stock had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

PATH has been the topic of a number of other research reports. DA Davidson started coverage on shares of UiPath in a report on Friday, September 5th. They set a "neutral" rating and a $12.00 price target on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a research report on Friday, September 5th. Truist Financial reduced their price target on UiPath from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, September 5th. Canaccord Genuity Group cut their price target on shares of UiPath from $16.00 to $15.00 and set a "buy" rating on the stock in a research note on Monday, September 8th. Finally, Zacks Research upgraded UiPath from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 8th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $13.21.

UiPath Stock Up 5.2%

UiPath stock traded up $0.77 during mid-day trading on Wednesday, hitting $15.59. 34,459,771 shares of the company's stock traded hands, compared to its average volume of 21,861,838. The firm has a 50 day moving average price of $11.74 and a 200 day moving average price of $11.93. The company has a market cap of $8.28 billion, a PE ratio of 519.67, a price-to-earnings-growth ratio of 5.48 and a beta of 1.07. UiPath has a one year low of $9.38 and a one year high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The business had revenue of $361.73 million for the quarter, compared to the consensus estimate of $347.36 million. During the same period in the prior year, the business posted $0.04 earnings per share. UiPath's revenue for the quarter was up 14.6% compared to the same quarter last year. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, analysts expect that UiPath will post -0.17 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In other UiPath news, CEO Daniel Dines sold 122,734 shares of the business's stock in a transaction dated Wednesday, October 8th. The shares were sold at an average price of $14.89, for a total value of $1,827,509.26. Following the transaction, the chief executive officer owned 736,404 shares in the company, valued at approximately $10,965,055.56. The trade was a 14.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Brad Brubaker sold 66,665 shares of the firm's stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $15.00, for a total value of $999,975.00. Following the sale, the insider directly owned 690,519 shares in the company, valued at approximately $10,357,785. This represents a 8.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,692,334 shares of company stock worth $21,619,319 over the last three months. 23.19% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in UiPath by 3.0% during the first quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company's stock valued at $495,029,000 after buying an additional 1,396,972 shares in the last quarter. TFG Asset Management GP Ltd raised its position in UiPath by 53.3% during the second quarter. TFG Asset Management GP Ltd now owns 13,722,244 shares of the company's stock valued at $175,645,000 after purchasing an additional 4,772,244 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of UiPath by 76.0% during the second quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company's stock worth $145,732,000 after purchasing an additional 4,926,341 shares during the period. Federated Hermes Inc. increased its stake in UiPath by 40.7% in the second quarter. Federated Hermes Inc. now owns 8,048,321 shares of the company's stock valued at $103,019,000 after purchasing an additional 2,328,225 shares in the last quarter. Finally, State Street Corp increased its stake in UiPath by 5.0% in the 2nd quarter. State Street Corp now owns 8,032,345 shares of the company's stock valued at $102,814,000 after buying an additional 378,851 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.